Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
ABOUT US
Edit submissions
Media kit
Innovation Awards
Industry News
Affymax plunges 85% on recall of anemia drug
Feb. 27, 2013
Shares of Affymax Inc. plummeted more than 85% Monday after the company recalled its antianemia drug Omontys following a handful of fatal reactions that followed use of the medication in first-time users.
Read the full story here.
Latest from Industry News
Celltrion updates strategy for potential Trump reciprocal tariffs on pharmaceuticals
Biopharma groups seek changes to FDA’s innovative manufacturing strategy
Sanofi CD38 antibody delivers in phase 3 trial
Pfizer to let go of 791 employees at NJ site
Load More Content